| Literature DB >> 32603735 |
Wei Liang1, Kosuke Yamahara2, Camila Hernando-Erhard3, Simon Lagies4, Nicola Wanner5, Huan Liang3, Christoph Schell6, Bernd Kammerer7, Tobias B Huber8, Tillmann Bork3.
Abstract
Podocyte maintenance and stress resistance are exquisitely based on high basal rates of autophagy making these cells a unique model to unravel mechanisms of autophagy regulation. Polyamines have key cellular functions such as proliferation, nucleic acid biosynthesis and autophagy. Here we test whether endogenous spermidine signaling is a driver of basal and dynamic autophagy in podocytes by using genetic and pharmacologic approaches to interfere with different steps of polyamine metabolism. Translational studies revealed altered spermidine signaling in focal segmental glomerulosclerosis in vivo and in vitro. Exogenous spermidine supplementation emerged as new treatment strategy by successfully activating autophagy in vivo via inhibition of EP300, a protein with an essential role in controlling cell growth, cell division and prompting cells to differentiate to take on specialized functions. Surprisingly, gas chromatography-mass spectroscopy based untargeted metabolomics of wild type and autophagy deficient primary podocytes revealed a positive feedback mechanism whereby autophagy itself maintains polyamine metabolism and spermidine synthesis. The transcription factor MAFB acted as an upstream regulator of polyamine metabolism. Thus, our data highlight a novel positive feedback loop of autophagy and spermidine signaling allowing maintenance of high basal levels of autophagy as a key mechanism to sustain the filtration barrier. Hence, spermidine supplementation may emerge as a new therapeutic to restore autophagy in glomerular disease.Entities:
Keywords: LC3; MAFB; autophagy; podocyte; polyamine; spermidine
Mesh:
Substances:
Year: 2020 PMID: 32603735 DOI: 10.1016/j.kint.2020.06.016
Source DB: PubMed Journal: Kidney Int ISSN: 0085-2538 Impact factor: 10.612